Section Arrow
SPRY.NASDAQ
- ARS Pharmaceuticals
Quotes are at least 15-min delayed:2026/01/09 09:09 EST
Pre Market
Last
 12.4
+1.45 (+13.24%)
Bid
12.25
Ask
12.5
High 13.475 
Low 11 
Volume 281.19K 
Regular Hours (Closed)
Last
 --
-- (--)
Day High 
-- 
Prev. Close
10.95 
1-M High
11.99 
Volume 
-- 
Bid
12.25
Ask
12.5
Day Low
-- 
Open
-- 
1-M Low
9.765 
Market Cap 
1.08B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 11.35 
20-SMA 10.97 
50-SMA 9.64 
52-W High 18.9 
52-W Low 6.66 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.81/-0.04
Enterprise Value
1.08B
Balance Sheet
Book Value Per Share
1.49
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
89.15M
Operating Revenue Per Share
0.00
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ZYMEZymeworks-------- 
Pre Market 23.3 +0.2 +0.87%
ZVRAZevra Therapeutics-------- 
Pre Market 8.65 +0.02 +0.23%
ZURAZura Bio Limited-------- 
Pre Market 5.26 0 0.00%
ZNTLZentalis Pharmaceuticals-------- 
Pre Market 3.1794 +0.3394 +11.95%
ZLABZai Lab Limited-------- 
Pre Market 18.6 +0.1 +0.54%
Industry overview quotes are at least 15 minutes delayed
Business Description
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.